Rivaroxaban
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
43598-981 -
Package NDC
43598-981-18 -
Package NDC
43598-981-60 -
Package NDC
43598-981-78 -
Application number
ANDA208534 -
SPL ID
eafdf7d8-5014-31c8-daa1-09fc017f5018 -
SPL set ID
122e6f78-067b-9065-adb2-ec7fec9f008e -
UNII
9NDF7JZ4M3 -
RxCUI
2059015
What the source publishes
- Labeler
- Dr.Reddy's Laboratories, Inc.
- Active ingredients
- Rivaroxaban
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Rivaroxaban",
"splId": "eafdf7d8-5014-31c8-daa1-09fc017f5018",
"labels": [
{
"setId": "122e6f78-067b-9065-adb2-ec7fec9f008e",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=122e6f78-067b-9065-adb2-ec7fec9f008e",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=122e6f78-067b-9065-adb2-ec7fec9f008e"
}
],
"routes": [
"ORAL"
],
"labeler": "Dr.Reddy's Laboratories, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "180 TABLET in 1 BOTTLE (43598-981-18)",
"package_ndc": "43598-981-18",
"identifierStatus": "well-formed",
"marketing_start_date": "20250514"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (43598-981-60)",
"package_ndc": "43598-981-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20250514"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (43598-981-78) / 10 TABLET in 1 BLISTER PACK (43598-981-79)",
"package_ndc": "43598-981-78",
"identifierStatus": "well-formed",
"marketing_start_date": "20250514"
}
],
"productId": "43598-981_eafdf7d8-5014-31c8-daa1-09fc017f5018",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "43598-981",
"deaSchedule": null,
"genericName": "Rivaroxaban",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RIVAROXABAN",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA208534",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250514",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175635",
"N0000175637"
],
"upc": [
"0343598981604"
],
"unii": [
"9NDF7JZ4M3"
],
"rxcui": [
"2059015"
],
"spl_set_id": [
"122e6f78-067b-9065-adb2-ec7fec9f008e"
],
"pharm_class_epc": [
"Factor Xa Inhibitor [EPC]"
],
"pharm_class_moa": [
"Factor Xa Inhibitors [MoA]"
],
"manufacturer_name": [
"Dr.Reddy's Laboratories, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:43598-981_eafdf7d8-5014-31c8-daa1-09fc017f5018"